Cardiovascular MRI in small animals

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 1, 2010, Pages 35-47

  Makowski, Marcus R ^a   Wiethoff, Andrea J ^a   Jansen, Christian Hp ^a   Botnar, René M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

cardiovascular; molecular; MRI; murine; preclinical

Indexed keywords

GADOLINIUM PENTETATE; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ANATOMICAL VARIATION; ANESTHESIA; BODY POSITION; BODY TEMPERATURE MONITORING; BREATHING; CARDIOVASCULAR DISEASE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; MAGNETIC RESONANCE ANGIOGRAPHY; MONITORING; MYOCARDIAL PERFUSION IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; REPRODUCIBILITY; REVIEW; ANIMAL; DISEASE MODEL; GENETICS; INSTRUMENTATION; METHODOLOGY; MOUSE; PATHOLOGY; RABBIT; RAT;

ANIMALS; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; MAGNETIC RESONANCE IMAGING; MICE; RABBITS; RATS; REPRODUCIBILITY OF RESULTS;

EID: 77949527558     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.126     Document Type: Review

References (105)

1. Herold V, Morchel P, Faber C et al. In vivo quantitative three-dimensional motion mapping of the murine myocardium with PC-MRI at 17.6 T. Magn. Reson. Med. 55(5), 1058-1064 (2006).
2. Wiesmann F, Ruff J, Engelhardt S et al. Dobutamine-stress magnetic resonance microimaging in mice : acute changes of cardiac geometry and function in normal and failing murine hearts. Circ. Res. 88(6), 563-569 (2001).
3. Schneider JE, Cassidy P, Lygate C et al. Fast, high-resolution in vivo cine magnetic resonance imaging in normal and failing mouse hearts on a vertical 11.7 T system. J. Magn. Reson. Imaging 18(6), 691-701 (2003).
4. Schneider JE, Lanz T, Barnes H et al. Ultra-fast and accurate assessment of cardiac function in rats using accelerated MRI at 9.4 Tesla. Magn. Reson. Med. 59(3), 636-641 (2008).
5. Brockmann MA, Kemmling A, Groden C. Current issues and perspectives in small rodent magnetic resonance imaging using clinical MRI scanners. Methods 43, 79-87 (2007).
6. Gilson WD, Kraitchman DL. Cardiac magnetic resonance imaging in small rodents using clinical 1.5 T and 3.0 T scanners. Methods 43(1), 35-45 (2007).
7. Beuf O, Jaillon F, Saint-Jalmes H. Small-animal MRI: signal-to-noise ratio comparison at 7 and 1.5 T with multiple- animal acquisition strategies. MAGMA 19(4), 202-208 (2006).
8. Lovell DP. Variation in barbiturate sleeping time in mice. 3. Strain X environment interactions. Lab. Anim. 20(4), 307-312 (1986).
9. van Bogaert MJV, Groenink L, Oosting RS et al. Mouse strain differences in autonomic responses to stress. Genes Brain Behav. 5(2), 139-149 (2006).
10. Shi W, Brown MD, Wang X et al. Genetic backgrounds but not sizes of atherosclerotic lesions determine medial destruction in the aortic root of apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23(10), 1901-1906 (2003).
11. Thaker PH, Han LY, Kamat AA et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat. Med. 12(8), 939-944 (2006).
12. Daugherty A, Rateri DL. Development of experimental designs for atherosclerosis studies in mice. Methods 36(2), 129-138 (2005).
13. Curry BB. Animal models used in identifying gender-related differences. Int. J. Toxicol. 20(3), 153-160 (2001).
14. Czerniak R. Gender-based differences in pharmacokinetics in laboratory animal models. Int. J. Toxicol. 20(3), 161-163 (2001).
15. Kato R, Yamazoe Y. Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity. Toxicol. Lett. 64-65, 661-667 (1992).
16. Morton DB, Jennings M, Buckwell A et al. Refining procedures for the administration of substances. Report of the BVAAWF/ FRAME/RSPCA/UFAW Joint Working Group on Refinement. British Veterinary Association Animal Welfare Foundation/ Fund for the Replacement of Animals in Medical Experiments/Royal Society for the Prevention of Cruelty to Animals/ Universities Federation for Animal Welfare. Lab. Anim. 35(1), 1-41 (2001).
17. Kohn D, Wixson S, White W, Benson G. Anesthesia and Analgesia in Laboratory Animals. Academic Press, NY, USA (1997).
18. Roth DM, Swaney JS, Dalton ND, Gilpin EA, Ross J. Impact of anesthesia on cardiac function during echocardiography in mice. Am. J. Physiol. Heart Circ. Physiol. 282(6), H2134-H2140 (2002).
19. Janssen BJ, De Celle T, Debets JJ et al. Effects of anesthetics on systemic hemodynamics in mice. Am. J. Physiol. Heart Circ. Physiol. 287(4), H1618-H1624 (2004).
20. Zuurbier CJ, Emons VM, Ince C. Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strain. Am. J. Physiol. Heart Circ. Physiol. 282(6), H2099-H2105 (2002).
21. Kober F, Iltis I, Cozzone PJ, Bernard M. Cine-MRI assessment of cardiac function in mice anesthetized with ketamine/ xylazine and isoflurane. MAGMA 17(3-6), 157-161 (2004).
22. Kober F, Iltis I, Cozzone PJ, Bernard M. Myocardial blood flow mapping in mice using high-resolution spin labeling magnetic resonance imaging: influence of ketamine/xylazine and isoflurane anesthesia. Magn. Reson. Med. 53(3), 601-606 (2005).
23. Stein AB, Tiwari S, Thomas P et al. Effects of anesthesia on echocardiographic assessment of left ventricular structure and function in rats. Basic Res. Cardiol. 102(1), 28-41 (2007).
24. Berry CJ, Thedens DR, Light-McGroary K et al. Effects of deep sedation or general anesthesia on cardiac function in mice undergoing cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 11(1), 16 (2009).
25. Brutkiewicz S, Mendonca M, Stantz K et al. The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging. Luminescence 22(3), 221-228 (2007).
26. Meijer MK, Spruijt BM, van Zutphen LFM, Baumans V. Effect of restraint and injection methods on heart rate and body temperature in mice. Lab. Anim. 40(4), 382-391 (2006).
27. Meijer MK, Lemmens AG, Van Zutphen BFM, Baumans V. Urinary corticosterone levels in mice in response to intraperitoneal injections with saline. J. Appl. Anim. Welf. Sci. 8(4), 279-283 (2005).
28. Cassidy PJ, Schneider JE, Grieve SM et al. Assessment of motion gating strategies for mouse magnetic resonance at high magnetic fields. J. Magn. Reson. Imaging 19(2), 229-237 (2004).
29. Polson MJ, Barker AT, Gardiner S. The effect of rapid rise-time magnetic fields on the ECG of the rat. Clin. Phys. Physiol. Meas. 3(3), 231-234 (1982).
30. Shetty AN. Suppression of radiofrequency interference in cardiac gated MRI: a simple design. Magn. Reson. Med. 8(1), 84-88 (1988).
31. Hiba B, Richard N, Janier M, Croisille P. Cardiac and respiratory double self-gated cine MRI in the mouse at 7 T. Magn. Reson. Med. 55(3), 506-513 (2006).
32. Brau AC, Wheeler CT, Hedlund LW, Johnson GA. Fiber-optic stethoscope: a cardiac monitoring and gating system for magnetic resonance microscopy. Magn. Reson. Med. 47(2), 314-321 (2002).
33. Namati E, Chon D, Thiesse J et al. In vivo micro-CT lung imaging via a computer- controlled intermittent iso-pressure breath hold (IIBH) technique. Phys. Med. Biol. 51(23), 6061-6075 (2006). (Pubitemid 46217649)
34. Dulce MC, Mostbeck GH, Friese KK, Caputo GR, Higgins CB. Quantification of the left ventricular volumes and function with cine MR imaging: comparison of geometric models with three-dimensional data. Radiology 188(2), 371-376 (1993).
35. Ruff J, Wiesmann F, Hiller KH et al. Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn. Reson. Med. 40(1), 43-48 (1998).
36. Slawson SE, Roman BB, Williams DS, Koretsky AP. Cardiac MRI of the normal and hypertrophied mouse heart. Magn. Reson. Med. 39(6), 980-987 (1998).
37. Berr SS, Roy RJ, French BA et al. Black blood gradient echo cine magnetic resonance imaging of the mouse heart. Magn. Reson. Med. 53(5), 1074-1079 (2005).
38. Franco F, Thomas GD, Giroir B et al. Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-a. Circulation 99(3), 448-454 (1999).
39. Wiesmann F, Frydrychowicz A, Rautenberg J et al. Analysis of right ventricular function in healthy mice and a murine model of heart failure by in vivo MRI. Am. J. Physiol. Heart Circ. Physiol. 283(3), H1065-H1071 (2002).
40. Wiesmann F, Ruff J, Hiller KH et al. Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice. Am. J. Physiol. Heart Circ. Physiol. 278(2), H652-H657 (2000).
41. Winter EM, Grauss RW, Atsma DE et al. Left ventricular function in the post-infarct failing mouse heart by magnetic resonance imaging and conductance catheter: a comparative analysis. Acta Physiol. 194(2), 111-122 (2008).
42. Axel L, Dougherty L. MR imaging of motion with spatial modulation of magnetization. Radiology 171(3), 841-845 (1989).
43. Henson RE, Song SK, Pastorek JS, Ackerman JJ, Lorenz CH. Left ventricular torsion is equal in mice and humans. Am. J. Physiol. Heart Circ. Physiol. 278(4), H1117-H1123 (2000).
44. Zhou R, Pickup S, Glickson JD, Scott CH, Ferrari VA. Assessment of global and regional myocardial function in the mouse using cine and tagged MRI. Magn. Reson. Med. 49(4), 760-764 (2003).
45. Epstein FH, Yang Z, Gilson WD et al. MR tagging early after myocardial infarction in mice demonstrates contractile dysfunction in adjacent and remote regions. Magn. Reson. Med. 48(2), 399-403 (2002).
46. Stuber M, Spiegel MA, Fischer SE et al. Single breath-hold slice-following CSPAMM myocardial tagging. MAGMA 9(1-2), 85-91 (1999).
47. Young AA, French BA, Yang Z et al. Reperfused myocardial infarction in mice: 3D mapping of late gadolinium enhancement and strain. J. Cardiovasc. Magn. Reson. 8(5), 685-692 (2006).
48. Botnar R, Leiner T, Kissinger K et al. Improved motion compensation in coronary MRA (Abstr). Proc. Int. Soc. Magn. Reson. Med. (2004.).
49. Spotnitz HM. Macro design, structure, and mechanics of the left ventricle. J. Thorac. Cardiovasc. Surg. 119(5), 1053-1077 (2000).
50. Moore CC, McVeigh ER, Zerhouni EA. Quantitative tagged magnetic resonance imaging of the normal human left ventricle. Top. MRI 11(6), 359-371 (2000).
51. Osman NF, Kerwin WS, McVeigh ER, Prince JL. Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging. Magn. Reson. Med. 42(6), 1048-1060 (1999).
52. Heijman E, Strijkers GJ, Habets J, Janssen B, Nicolay K. Magnetic resonance imaging of regional cardiac function in the mouse. MAGMA 17(3-6), 170-178 (2004).
53. Kraitchman DL, Sampath S, Castillo E et al. Quantitative ischemia detection during cardiac magnetic resonance stress testing by use of FastHARP. Circulation 107(15), 2025-2030 (2003).
54. Thomas D, Ferrari V, Janik M et al. Quantitative assessment of regional myocardial function in a rat model of myocardial infarction using tagged MRI. MAGMA 17(3-6), 179-187 (2004).
55. Gilson WD, Yang Z, French BA, Epstein FH. Complementary displacement- encoded MRI for contrast-enhanced infarct detection and quantification of myocardial function in mice. Magn. Reson. Med. 51(4), 744-752 (2004).
56. Gilson WD, Yang Z, French BA, Epstein FH. Measurement of myocardial mechanics in mice before and after infarction using multislice displacement- encoded MRI with 3D motion encoding. Am. J. Physiol. Heart Circ. Physiol. 288(3), H1491-H1497 (2005).
57. Benjelloun H, Cranney GB, Kirk KA et al. Interstudy reproducibility of biplane cine nuclear magnetic resonance measurements of left ventricular function. Am. J. Cardiol. 67(16), 1413-1420 (1991).
58. Moore CC, Lugo-Olivieri CH, McVeigh ER, Zerhouni EA. Three-dimensional systolic strain patterns in the normal human left ventricle: characterization with tagged MR imaging. Radiology 214(2), 453-466 (2000).
59. Streif JU, Herold V, Szimtenings M et al. In vivo time-resolved quantitative motion mapping of the murine myocardium with phase contrast MRI. Magn. Reson. Med. 49(2), 315-321 (2003).
60. Streif JU, Nahrendorf M, Hiller KH et al. In vivo assessment of absolute perfusion and intracapillary blood volume in the murine myocardium by spin labeling magnetic resonance imaging. Magn. Reson. Med. 53(3), 584-592 (2005).
61. Trabold F, Pons S, Hagege AA et al. Cardiovascular phenotypes of kinin B2 receptor- and tissue kallikrein-deficient mice. Hypertension 40(1), 90-95 (2002).
62. Decking UK, Pai VM, Bennett E et al. High-resolution imaging reveals a limit in spatial resolution of blood flow measurements by microspheres. Am. J. Physiol. Heart Circ. Physiol. 287(3), H1132-H1140 (2004).
63. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 104(23), 2838-2842 (2001).
64. Yang Z, Berr SS, Gilson W, Toufektsian MC, French BA. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation 109(9), 1161-1167 (2004).
65. Flacke S, Allen JS, Chia JM et al. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. Radiology 226(3), 731-738 (2003).
66. Koenig SH, Spiller M, Brown RD, Wolf GL. Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA). Magn. Reson. Med. 3(5), 791-795 (1986).
67. Dill T, Ekinci O, Hansel J et al. Delayed contrast-enhanced magnetic resonance imaging for the detection of autoimmune myocarditis and long-term follow-up. J. Cardiovasc. Magn. Reson. 7(2), 521-523 (2005).
68. Tandri H, Saranathan M, Rodriguez ER et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed- enhancement magnetic resonance imaging. J. Am. Coll. Cardiol. 45(1), 98-103 (2005).
69. Wehrli FW. Time-of-flight effects in MR imaging of flow. Magn. Reson. Med. 14(2), 187-193 (1990).
70. Krings T, Hans FJ, Moller-Hartmann W et al. Time-of-flight-, phase contrast and contrast enhanced magnetic resonance angiography for pre-interventional determination of aneurysm size, configuration, and neck morphology in an aneurysm model in rabbits. Neurosci. Lett. 326(1), 46-50 (2002).
71. Yang YM, Feng X, Yao ZW et al. Magnetic resonance angiography of carotid and cerebral arterial occlusion in rats using a clinical scanner. J. Neurosci. Methods 167(2), 176-183 (2008).
72. Reese T, Bochelen D, Sauter A, Beckmann N, Rudin M. Magnetic resonance angiography of the rat cerebrovascular system without the use of contrast agents. NMR Biomed. 12(4), 189-196 (1999).
73. Gerriets T, Li F, Silva MD et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J. Neurosci. Methods 122(2), 201-211 (2003).
74. Fehm NP, Vatankhah B, Dittmar MS et al. Application of clinical scanners in rats: experimental carotid imaging using magnetic resonance imaging, spiral computed tomography, and color duplex ultrasound. J. Neuroimaging 15(4), 319-325 (2005).
75. Choy M, Ganesan V, Thomas DL et al. The chronic vascular and haemodynamic response after permanent bilateral common carotid occlusion in newborn and adult rats. J. Cereb. Blood Flow Metab. 26(8), 1066-1075 (2006).
76. Besselmann M, Liu M, Diedenhofen M, Franke C, Hoehn M. MR angiographic investigation of transient focal cerebral ischemia in rat. NMR Biomed. 14(5), 289-296 (2001).
77. Libby P. Inflammation in atherosclerosis. Nature 420(6917), 868-874 (2002).
78. Nahrendorf M, Jaffer FA, Kelly KA et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114(14), 1504-1511 (2006).
79. Mulder WJ, Strijkers GJ, Griffioen AW et al. A liposomal system for contrast- enhanced magnetic resonance imaging of molecular targets. Bioconjug. Chem. 15(4), 799-806 (2004).
80. Dardzinski BJ, Schmithorst VJ, Holland SK et al. MR imaging of murine arthritis using ultrasmall superparamagnetic iron oxide particles. Magn. Reson. Imaging 19(9), 1209-1216 (2001).
81. Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52(2), 237-268 (2000).
82. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat. Rev. Drug Discov. 3(11), 913-925 (2004).
83. Purushothaman KR, Sanz J, Zias E, Fuster V, Moreno PR. Atherosclerosis neovascularization and imaging. Curr. Mol. Med. 6(5), 549-556 (2006).
84. Winter PM, Neubauer AM, Caruthers SD et al. Endothelial a(v)p3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 26(9), 2103-2109 (2006).
85. Kerwin WS, O'Brien KD, Ferguson MS et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology 241(2), 459-468 (2006).
86. Kooi ME, Cappendijk VC, Cleutjens KB et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107(19), 2453-2458.
87. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103(3), 415-422 (2001).
88. Amirbekian V, Lipinski MJ, Briley-Saebo KC et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc. Natl Acad. Sci. USA 104(3), 961-966 (2007).
89. Flacke S, Fischer S, Scott MJ et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 104(11), 1280-1285 (2001).
90. Botnar RM, Perez AS, Witte S et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 109(16), 2023-2029 (2004).
91. Spuentrup E, Buecker A, Katoh M et al. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Circulation 111(11), 1377-1382 (2005). (Pubitemid 40396803)
92. Botnar RM, Buecker A, Wiethoff AJ et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent. Circulation 110(11), 1463-1466
93. Yu X, Song SK, Chen J et al. High- resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent. Magn. Reson. Med. 44(6), 867-872 (2000).
94. Sirol M, Itskovich VV, Mani V et al. Lipid-rich atherosclerotic plaques detected by gadofluorine-enhanced in vivo magnetic resonance imaging. Circulation 109(23), 2890-2896 (2004).
95. Chen W, Vucic E, Leupold E et al. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis. Contrast Media Mol. Imaging 3(6), 233-242 (2008).
96. Krombach GA, Wendland MF, Higgins CB, Saeed M. MR imaging of spatial extent of microvascular injury in reperfused ischemically injured rat myocardium: value of blood pool ultrasmall superparamagnetic particles of iron oxide. Radiology 225(2), 479-486 (2002).
97. Blankenberg FG, Katsikis PD, Tait JF et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl Acad. Sci. USA 95(11), 6349-6354 (1998).
98. Sosnovik DE, Schellenberger EA, Nahrendorf M et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn. Reson. Med. 54(3), 718-724 (2005).
99. Hiller KH, Waller C, Nahrendorf M, Bauer WR, Jakob PM. Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol. Imaging 5(2), 115-121 (2006).
100. Kanno S, Wu YJ, Lee PC et al. Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation 104(8), 934-938 (2001).
101. Hurlston SE, Brey WW, Suddarth SA, Johnson GA. A high-temperature superconducting Helmholtz probe for microscopy at 9.4 T. Magn. Reson. Med. 41(5), 1032-1038 (1999).
102. Nouls JC, Izenson MG, Greeley HP, Johnson GA. Design of a superconducting volume coil for magnetic resonance microscopy of the mouse brain. J. Magn. Reson. 191(2), 231-238 (2008).
103. Black RD, Early TA, Roemer PB et al. A high-temperature superconducting receiver for nuclear magnetic resonance microscopy. Science 259(5096), 793-795 (1993).
104. Hockings PD, Roberts T, Galloway GJ et al. Repeated three-dimensional magnetic resonance imaging of atherosclerosis development in innominate arteries of low-density lipoprotein receptor-knockout mice. Circulation 106(13), 1716-1721 (2002).
105. Nahrendorf M, Sosnovik D, Chen JW et al. Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia- reperfusion injury. Circulation 117(9), 1153-1160 (2008).